The Emerging Role of Pimavanserin in the Management of Parkinson’s Disease Psychosis

作者: Neal Hermanowicz , Gustavo Alva , Fernando Pagan , Alberto J. Espay , Amita Patel

DOI: 10.18553/JMCP.2017.23.6-B.S2

关键词: NursingMEDLINEQuality of life (healthcare)Disease management (health)PimavanserinPatient educationMedicineGeriatricsPharmacyDisease

摘要: A panel of experts drawn from neurology, psychiatry, geropsychiatry, geriatrics, and pharmacy representatives 3 health plans convened in New York City on July 30, 2016, with the objective sharing opinions, ideas, information regarding optimal management Parkinson’s disease psychosis (PDP). Three key points emerged discussion: (1) Because nature PDP, finding appropriate treatment can prove challenging; (2) emerging therapies may present an opportunity for effective management; (3) moving forward, provider patient education PDP available options is essential well-managed symptoms better quality life. The reviewed current practices formulated recommendations forward PDP. DISCLOSURES: This project manuscript was funded by ACADIA Pharmaceuticals developed Magellan Rx Management. Lopes Farnum are employees Kremens has rec...

参考文章(26)
E. R. Dorsey, R. Constantinescu, J. P. Thompson, K. M. Biglan, R. G. Holloway, K. Kieburtz, F. J. Marshall, B. M. Ravina, G. Schifitto, A. Siderowf, C. M. Tanner, Projected number of people with parkinson disease in the most populous nations, 2005 through 2030 Neurology. ,vol. 68, pp. 384- 386 ,(2007) , 10.1212/01.WNL.0000247740.47667.03
Juan Carlos Gómez-Esteban, Beatriz Tijero, Johanne Somme, Roberto Ciordia, Koldo Berganzo, Idoia Rouco, Jose Luis Bustos, Maria Antonia Valle, Elena Lezcano, Juan J. Zarranz, Impact of psychiatric symptoms and sleep disorders on the quality of life of patients with Parkinson’s disease Journal of Neurology. ,vol. 258, pp. 494- 499 ,(2011) , 10.1007/S00415-010-5786-Y
Tiffini Voss, Daun Bahr, Jeffrey Cummings, Roger Mills, Bernard Ravina, Hilde Williams, Performance of a shortened Scale for Assessment of Positive Symptoms for Parkinson's disease psychosis. Parkinsonism & Related Disorders. ,vol. 19, pp. 295- 299 ,(2013) , 10.1016/J.PARKRELDIS.2012.10.022
Christopher G. Goetz, Wenqing Fan, Sue Leurgans, Bryan Bernard, Glenn T. Stebbins, The Malignant Course of “Benign Hallucinations” in Parkinson Disease Archives of Neurology. ,vol. 63, pp. 713- 716 ,(2006) , 10.1001/ARCHNEUR.63.5.713
Jose M. Rabey, Tatiana Prokhorov, Ala Miniovitz, Eugenia Dobronevsky, Colin Klein, Effect of quetiapine in psychotic Parkinson's disease patients: a double-blind labeled study of 3 months' duration. Movement Disorders. ,vol. 22, pp. 313- 318 ,(2007) , 10.1002/MDS.21116
Edmund P. Harrigan, Jeffrey J. Miceli, Richard Anziano, Eric Watsky, Karen R. Reeves, Neal R. Cutler, John Sramek, Thomas Shiovitz, Michelle Middle, A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition. Journal of Clinical Psychopharmacology. ,vol. 24, pp. 62- 69 ,(2004) , 10.1097/01.JCP.0000104913.75206.62
E. B. Forsaa, J. P. Larsen, T. Wentzel-Larsen, G. Alves, What predicts mortality in Parkinson disease?: A prospective population-based long-term study Neurology. ,vol. 75, pp. 1270- 1276 ,(2010) , 10.1212/WNL.0B013E3181F61311
Colin Klein, Tatiana Prokhorov, Ala Miniovitz, Eugenia Dobronevsky, Jose Martin Rabey, Admission of Parkinsonian patients to a neurological ward in a community hospital Journal of Neural Transmission. ,vol. 116, pp. 1509- 1512 ,(2009) , 10.1007/S00702-009-0302-1
K. Ray Chaudhuri, Cristina Prieto-Jurcynska, Yogini Naidu, Tanya Mitra, Belen Frades-Payo, Susanne Tluk, Anne Ruessmann, Per Odin, Graeme Macphee, Fabrizio Stocchi, William Ondo, Kapil Sethi, Anthony H.V. Schapira, Juan Carlos Martinez Castrillo, Pablo Martinez-Martin, The Nondeclaration of Nonmotor Symptoms of Parkinson's Disease to Health Care Professionals: An International Study Using the Nonmotor Symptoms Questionnaire Movement Disorders. ,vol. 25, pp. 704- 709 ,(2010) , 10.1002/MDS.22868